Harrow Inc (HROW)

May 14, 2025

Harrow Inc.: Opaleye management sells $150,055 in stock By Investing.com - Investing.com India

May 14, 2025

May 14, 2025

Harrow Inc.: Opaleye management sells $150,055 in stock - Investing.com

May 14, 2025

May 14, 2025

Jim Cramer on Harrow, Inc. (HROW) – “Eye Care’s a Good Biz – If It Makes Money, Don’t Walk Away Pre-Breakout” - Insider Monkey

May 14, 2025

May 14, 2025

Harrow to Present at Two Investor Conferences in May - Business Wire

May 14, 2025

May 13, 2025

Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock - Benzinga

May 13, 2025

May 13, 2025

Harrow Health, Inc. (NASDAQ:HROW) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 13, 2025

Harrow (HROW) Faces Price Target Cut Amid Q1 Earnings Miss | HRO - GuruFocus

May 13, 2025

May 13, 2025

HROW Stock Price Target Raised to $60 by Analyst | HROW Stock Ne - GuruFocus

May 13, 2025

May 12, 2025

Where Harrow Stands With Analysts - Benzinga

May 12, 2025

May 12, 2025

HROW Stock Update: Analyst Raises Price Target to $60 | HROW Sto - GuruFocus

May 12, 2025

May 10, 2025

Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 10, 2025

May 10, 2025

Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo Finance

May 10, 2025

May 10, 2025

Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Reven - GuruFocus

May 10, 2025

May 10, 2025

Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... By GuruFocus - Investing.com Canada

May 10, 2025

May 10, 2025

Harrow Health Reports Strong Q1 2025 Revenue Growth - TipRanks

May 10, 2025

May 09, 2025

Harrow Announces First-Quarter 2025 Financial Results - BioSpace

May 09, 2025

May 09, 2025

Transcript : Harrow, Inc., Q1 2025 Earnings Call, May 09, 2025 - marketscreener.com

May 09, 2025

May 09, 2025

Harrow Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 09, 2025

May 09, 2025

Harrow: Q1 Earnings Snapshot - CT Insider

May 09, 2025

May 08, 2025

Harrow Health Q1 2025 slides: revenue up 43% as ophthalmic portfolio expands - Investing.com

May 08, 2025

May 08, 2025

Harrow Health (HROW) Reports Q1 Revenue Miss Despite Growth - GuruFocus

May 08, 2025

May 08, 2025

Harrow Inc (HROW) Q1 2025 Earnings: EPS of -$0.50 Misses Estimate, Revenue at $47.8M Below Forecast - GuruFocus

May 08, 2025

May 08, 2025

Earnings Flash (HROW) HARROW INC. Reports Q1 Loss $0.38 Per Share - marketscreener.com

May 08, 2025

May 08, 2025

Harrow (HROW) Sees Promising Revenue Growth and Expansion Plans - GuruFocus

May 08, 2025

May 08, 2025

HROW Forecasts Surpassing $280 Million Revenue by 2025 | HROW St - GuruFocus

May 08, 2025

May 08, 2025

HROW Forecasts Surpassing $280 Million Revenue by 2025 | HROW Stock News - GuruFocus

May 08, 2025

May 08, 2025

Harrow (HROW) Sees Promising Revenue Growth and Expansion Plans | HROW Stock News - GuruFocus

May 08, 2025

May 08, 2025

Harrow Inc (HROW) Q1 2025 Earnings Report Preview: What to Look For - GuruFocus

May 08, 2025

May 08, 2025

Harrow to Report First Quarter 2025 Financial Results After Mark - GuruFocus

May 08, 2025

May 07, 2025

Examining the Future: Harrow's Earnings Outlook - Nasdaq

May 07, 2025

May 07, 2025

What To Expect From Harrow Inc (HROW) Q1 2025 Earnings - Yahoo Finance

May 07, 2025

May 05, 2025

Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 - Business Wire

May 05, 2025

May 04, 2025

Invesco Ltd. Lowers Position in Harrow, Inc. (NASDAQ:HROW) - Defense World

May 04, 2025

May 04, 2025

Harrow, Inc. (NASDAQ:HROW) Shares Sold by Wells Fargo & Company MN - Defense World

May 04, 2025

Apr 28, 2025

Harrow Inc (HROW) Shares Gap Down to $24.695 on Apr 28 - GuruFocus

Apr 28, 2025

Apr 26, 2025

Harrow and Nordic Pharma to launch generic version of Novartis' Maxitrol - MSN

Apr 26, 2025

Apr 26, 2025

JPMorgan Chase & Co. Lowers Stock Position in Harrow, Inc. (NASDAQ:HROW) - Defense World

Apr 26, 2025

Apr 24, 2025

Harrow (HROW) Partners with Nordic Pharma for Maxitrol Generic L - GuruFocus

Apr 24, 2025

Apr 24, 2025

Harrow Authorizes Nordic Group Unit to sell Generic Version of Maxitrol eye Treatment - marketscreener.com

Apr 24, 2025

Apr 24, 2025

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension) - Morningstar

Apr 24, 2025

Apr 23, 2025

LPL Financial LLC Has $699,000 Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World

Apr 23, 2025

Apr 21, 2025

Harrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Apr 21, 2025

Apr 21, 2025

Harrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Initiatives Propel Success - GuruFocus

Apr 21, 2025

Apr 18, 2025

Harrow Inc (NASDAQ: HROW) Jumps 2.74%: The Most Likely Path Going Forward - Stocksregister

Apr 18, 2025

Apr 10, 2025

Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C Patients - Business Wire

Apr 10, 2025